Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection)
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Subpotent: Low anti-factor IIa Potency.
Cause type: Wrong potency / content
Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.
Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20,
Compare with the code on your package — it is the most precise check available.
Drug: Heparin
From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.
| Product | Strength | Form & route | Labeler | Type |
|---|---|---|---|---|
| Heparin Sodium in Dextrose Heparin Sodium and Dextrose NDC 00264-9587 |
HEPARIN SODIUM 10000 [USP'U]/100mL; DEXTROSE MONOHYDRATE 5 g/100mL | Injection Intravenous |
B. Braun Medical Inc. | Rx |
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene
Presence of Particulate matter.
Presence of Particulate Matter.
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.